Here is a link to the original story on the team's website.
BOWIE, Md. – It’s hard to imagine a baseball game without peanuts, but in a new collaboration between Minor League Baseball®(MiLB™) and AUVI-Q®(epinephrine injection, USP), fans that suffer from peanut allergies can enjoy America’s national pastime with less concern.
On Sunday, August 13 the Bowie Baysox will be hosting a peanut-free game, sponsored by AUVI-Q. The game will feature no in-park sales of peanuts or products containing peanut ingredients. Throughout the game, in-park messaging and informational displays will be available for fans to learn more about AUVI-Q.
“With the help of AUVI-Q supporting our commitment to fans, we can create an environment where fans with peanut allergies can come to the ballpark and enjoy a game to its fullest,” said Brian Shallcross, General Manager of the Baysox. “We hope to see many new faces experiencing their first Minor League Baseball game because of our peanut-free night.”
Earlier this month, Minor League Baseball and AUVI-Q announced a multi-year agreement, making AUVI-Q the “Official Epinephrine Auto-Injector (EAI) of Minor League Baseball,” where a number of MiLB teams across the country will host “Peanut-Free Game Days” this season and next season. AUVI-Q is an FDA-approved prescription medicine used to treat life-threatening allergic reactions, including anaphylaxis, in people who are at risk for or have a history of serious allergic reactions. AUVI-Q is the first and only EAI with an auto-retractable needle and includes innovative features such as voice instructions. AUVI-Q is not a substitute for emergency medical treatment. AUVI-Q, manufactured by kaléo, is available by prescription nationwide. To learn more about AUVI-Q, please visit www.auvi-q.com.
The 2017 Bowie Baysox season is presented by Money One Federal Credit Union. The Baysox 2017 season is winding down. Don’t miss out as the Baysox make a playoff push. Single game tickets are available at http://www.baysox.com.
This story was not subject to the approval of the National Association of Professional Baseball Leagues or its clubs.